Bayer AG Company Profile (NASDAQ:BAYRY)

About Bayer AG (NASDAQ:BAYRY)

Bayer AG logoBayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Animal Health and Covestro. The Pharmaceuticals segment focuses on prescription products, especially for cardiology and women's healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The Pharmaceuticals division also comprises the radiology business. The Consumer Health segment is engaged in the development, production and marketing of mainly nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products. The Covestro segment is engaged in the development, production and marketing of raw materials for polyurethanes, polycarbonate granules and sheets and raw materials for coatings, adhesives.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: NASDAQ:BAYRY
  • CUSIP: N/A
  • Web: https://www.bayer.de/
Average Prices:
  • 50 Day Moving Avg: $33.55
  • 200 Day Moving Avg: $32.20
  • 52 Week Range: $22.88 - $35.18
P/E:
  • Trailing P/E Ratio: 20.22
  • Foreward P/E Ratio: 14.39
  • P/E Growth: 2.65
Dividend:
  • Dividend Yield: 2.1%
Profitability:
  • Net Margins: 10.90%
  • Return on Equity: 13.03%
  • Return on Assets: 6.36%
 

Frequently Asked Questions for Bayer AG (NASDAQ:BAYRY)

What is Bayer AG's stock symbol?

Bayer AG trades on the NASDAQ under the ticker symbol "BAYRY."

How often does Bayer AG pay dividends? What is the dividend yield for Bayer AG?

Bayer AG announced an annual dividend on Thursday, June 29th. Shareholders of record on Wednesday, May 3rd will be given a dividend of $2.157 per share on Monday, May 15th. The ex-dividend date is Monday, May 1st. View Bayer AG's Dividend History.

How were Bayer AG's earnings last quarter?

Bayer AG (NASDAQ:BAYRY) posted its earnings results on Thursday, July, 27th. The company reported $1.99 EPS for the quarter, topping the Zacks' consensus estimate of $1.87 by $0.12. The firm had revenue of $13.41 billion for the quarter, compared to analysts' expectations of $14.45 billion. Bayer AG had a return on equity of 13.03% and a net margin of 10.90%. View Bayer AG's Earnings History.

When will Bayer AG make its next earnings announcement?

Bayer AG is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Bayer AG.

Who are some of Bayer AG's key competitors?

Who are Bayer AG's key executives?

Bayer AG's management team includes the folowing people:

  • Werner Wenning, Chairman of the Supervisory Board
  • Werner Baumann, Chairman of the Management Board, Chief Executive Officer
  • Oliver Zuehlke, Vice Chairman of the Supervisory Board, Employee Representative
  • Johannes M. Dietsch, Chief Financial Officer, Member of the Management Board
  • Hartmut Klusik, Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director
  • Liam Condon, Member of the Management Board, Head of the Crop Science Division, Animal Health Business Unit
  • Kemal Malik, Member of the Management Board, Innovation and the Latin America Region
  • Erica Mann, Member of the Management Board, Head of the Consumer Health Division
  • Dieter Weinand, Member of the Management Board, Head of the Pharmaceuticals Division
  • Paul Achleitner, Member of the Supervisory Board

How do I buy Bayer AG stock?

Shares of Bayer AG can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer AG's stock price today?

One share of Bayer AG stock can currently be purchased for approximately $35.11.


MarketBeat Community Rating for Bayer AG (NASDAQ BAYRY)
Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  162 (Vote Outperform)
Underperform Votes:  197 (Vote Underperform)
Total Votes:  359
MarketBeat's community ratings are surveys of what our community members think about Bayer AG and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Bayer AG (NASDAQ:BAYRY) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: N/A
Consensus Price Target History for Bayer AG (NASDAQ:BAYRY)
Price Target History for Bayer AG (NASDAQ:BAYRY)
Analysts' Ratings History for Bayer AG (NASDAQ:BAYRY)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/25/2017BNP ParibasUpgradeNeutral -> OutperformLowView Rating Details
7/3/2017Berenberg BankDowngradeBuy -> HoldLowView Rating Details
2/24/2017Sanford C. BernsteinReiterated RatingOutperformN/AView Rating Details
1/4/2017J P Morgan Chase & CoUpgradeNeutral -> OverweightN/AView Rating Details
12/19/2016Jefferies Group LLCUpgradeHold -> BuyN/AView Rating Details
9/14/2016Goldman Sachs Group, Inc. (The)Reiterated RatingBuyN/AView Rating Details
8/25/2016Citigroup Inc.UpgradeNeutral -> BuyN/AView Rating Details
5/25/2016Commerzbank AgUpgradeHold -> BuyN/AView Rating Details
5/25/2016Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
5/25/2016DZ Bank AGReiterated RatingBuyN/AView Rating Details
4/27/2016Credit Suisse GroupDowngradeOutperform -> NeutralN/AView Rating Details
4/8/2016Nord/LBReiterated RatingBuyN/AView Rating Details
3/7/2016Barclays PLCUpgradeUnderweight -> Equal WeightN/AView Rating Details
12/10/2015HSBC Holdings plcUpgradeHold -> BuyN/AView Rating Details
10/26/2015Societe GeneraleReiterated RatingNeutralN/AView Rating Details
(Data available from 10/19/2015 forward)

Earnings

Earnings History for Bayer AG (NASDAQ:BAYRY)
Earnings by Quarter for Bayer AG (NASDAQ:BAYRY)
Earnings History by Quarter for Bayer AG (NASDAQ BAYRY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/26/2017$1.50N/AView Earnings Details
7/27/20176/30/2017$1.87$1.99$14.45 billion$13.41 billionViewN/AView Earnings Details
4/27/20173/31/2017$2.40$2.80$13.65 billion$14.11 billionViewN/AView Earnings Details
10/26/2016Q3$1.80$1.93$12.39 billion$12.57 billionViewListenView Earnings Details
10/29/2015Q3$1.65$1.88$12.79 billion$12.28 billionViewListenView Earnings Details
4/30/2015Q1 2015$2.35$2.33$12.81 billion$13.45 billionViewN/AView Earnings Details
2/26/2015Q4 2014$1.35$12.53 billionViewN/AView Earnings Details
7/30/2014Q2 2014$2.05$14.02 billionViewN/AView Earnings Details
4/24/2014Q1 2014$2.47$2.35$14.67 billion$14.59 billionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Bayer AG (NASDAQ:BAYRY)
Current Year EPS Consensus Estimate: $2.22 EPS
Next Year EPS Consensus Estimate: $2.44 EPS

Dividends

Dividend History by Quarter for Bayer AG (NASDAQ BAYRY)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/29/2017Annual$2.165/1/20175/3/20175/15/2017
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Bayer AG (NASDAQ:BAYRY)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Bayer AG (NASDAQ:BAYRY)
Latest Headlines for Bayer AG (NASDAQ:BAYRY)
Source:
DateHeadline
americanbankingnews.com logoBayer AG (BAYRY) to Release Earnings on Thursday
www.americanbankingnews.com - October 19 at 3:58 AM
seekingalpha.com logoMonsanto Ending On A Position Of Strength
seekingalpha.com - October 17 at 10:17 PM
seekingalpha.com logoPacBio Is A DNA Sequencing Standout
seekingalpha.com - October 17 at 5:14 PM
finance.yahoo.com logo[$$] Bayer to Sell Assets to BASF for $7 Billion Amid Scrutiny of Monsanto Megadeal
finance.yahoo.com - October 13 at 10:03 PM
finance.yahoo.com logoGermany’s stock market logs another record as Bayer rises on deal news
finance.yahoo.com - October 13 at 5:02 PM
nasdaq.com logoBASF To Buy Certain Assets From Bayer In EUR 5.9 Bln Cash Deal - Nasdaq
www.nasdaq.com - October 13 at 5:02 PM
wsj.com logoBayer to Sell Assets to BASF for $7 Billion, Subject to Monsanto Acquisition - Wall Street Journal
www.wsj.com - October 13 at 3:13 AM
seekingalpha.com logoUK's NHS to routinely offer Bayer's cancer med Stivarga - Seeking Alpha
seekingalpha.com - October 12 at 5:10 PM
seekingalpha.com logoBayer maintains Xarelto sales outlook despite study setback - Seeking Alpha
seekingalpha.com - October 6 at 8:30 AM
nasdaq.com logo4 Large-Cap Drug Stocks to Buy on Solid Momentum Ahead of Q3 - Nasdaq
www.nasdaq.com - October 5 at 7:30 PM
finance.yahoo.com logoMonsanto CEO talks Bayer deal timeline, mum on RTP specifics
finance.yahoo.com - October 5 at 2:24 PM
finance.yahoo.com logoBrazil agency says Bayer-Monsanto tie-up can hurt competition, urges conditions
finance.yahoo.com - October 5 at 2:24 PM
finance.yahoo.com logoMonsanto (MON) Tops Q4 Earnings, Bayer's Buyout Deal on Track
finance.yahoo.com - October 4 at 1:37 PM
wsj.com logoMonsanto Boosted by Continued Adoption of New Products - Wall Street Journal
www.wsj.com - October 4 at 1:37 PM
nasdaq.com logoMonsanto (MON) Tops Q4 Earnings, Bayer's Buyout Deal on Track - Nasdaq
www.nasdaq.com - October 4 at 1:37 PM
nasdaq.com logoMonsanto (MON) to Report Q4 Earnings: What's in the Cards? - Nasdaq
www.nasdaq.com - October 2 at 4:20 PM
nasdaq.com logoAdvanced Accelerator (AAAP) Cancer Therapy Approved in EU - Nasdaq
www.nasdaq.com - October 2 at 11:33 AM
seekingalpha.com logoBayer cuts Covestro holding below 25% - Seeking Alpha
seekingalpha.com - September 29 at 3:43 PM
rttnews.com logoBayer Sells Further Stake In Covestro For EUR 1 Bln
www.rttnews.com - September 29 at 8:54 AM
seekingalpha.com logoSenate confirms antitrust chief, queueing up deal discussions - Seeking Alpha
seekingalpha.com - September 28 at 12:42 AM
americanbankingnews.com logoBayer AG (BAYRY) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - September 27 at 2:28 AM
americanbankingnews.com logoBayer AG (BAYRY) Upgraded by BNP Paribas to "Outperform"
www.americanbankingnews.com - September 25 at 12:14 PM
americanbankingnews.com logo$0.38 EPS Expected for Bayer AG (BAYRY) This Quarter
www.americanbankingnews.com - September 25 at 8:52 AM
nasdaq.com logo5 Mega-Cap Stocks to Buy with Impressive Growth Prospects - Nasdaq
www.nasdaq.com - September 23 at 1:24 AM
nasdaq.com logoBayer (BAYRY) Focuses on Pipeline Development & Acquisitions ... - Nasdaq
www.nasdaq.com - September 23 at 1:24 AM
finance.yahoo.com logoBayer (BAYRY) Focuses on Pipeline Development & Acquisitions
finance.yahoo.com - September 22 at 11:20 AM
finance.yahoo.com logoIs Bayer AG (BAYRY) a Great Stock for Value Investors? - Yahoo Finance
finance.yahoo.com - September 20 at 10:17 PM
nasdaq.com logoBayer: Business In Brazil To Return To Normal In 2018 - Quick Facts - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
nasdaq.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
nasdaq.com logoIs Bayer AG (BAYRY) a Great Stock for Value Investors? - Nasdaq
www.nasdaq.com - September 19 at 9:25 PM
finance.yahoo.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoBayer Shares Dip After Group Pushes Monsanto Closing Date into 'Early 2018'
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoBayer dismisses antitrust concerns about digital farming
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoIs Bayer AG (BAYRY) a Great Stock for Value Investors?
finance.yahoo.com - September 19 at 4:21 PM
finance.yahoo.com logoNabriva's Lefamulin Positive in Pivotal Study, Stock Surges
finance.yahoo.com - September 19 at 4:21 PM
nasdaq.com logoMonsanto (MON) Upgraded to Buy on Robust Growth Drivers - Nasdaq
www.nasdaq.com - September 14 at 4:59 PM
nasdaq.com logoBASF Reportedly Bids For Bayer's Seed Assets - Nasdaq
www.nasdaq.com - September 14 at 4:59 PM
seekingalpha.com logoFDA OKs Bayer's lymphoma med Aliqopa - Seeking Alpha
seekingalpha.com - September 14 at 4:59 PM
finance.yahoo.com logoBASF's Late Grab for Bayer Seed Assets Marks Strategy Shift
finance.yahoo.com - September 14 at 4:59 PM
finance.yahoo.com logoBayer, Halvorsen's Viking Make Record Wager on Farming Tech
finance.yahoo.com - September 14 at 4:59 PM
nasdaq.com logoBayer Cuts Stake In Covestro, Places 9.4% Stake
www.nasdaq.com - September 13 at 2:38 AM
seekingalpha.com logoBayer submits European marketing application long-acting hemophilia A treatment
seekingalpha.com - September 7 at 4:24 PM
finance.yahoo.com logo[$$] Don’t Ignore Big Pharma’s New Breakthrough
finance.yahoo.com - September 6 at 4:15 PM
finance.yahoo.com logo[$$] Resilience Combines Three Medical-Device Businesses
finance.yahoo.com - September 6 at 4:15 PM
finance.yahoo.com logo[$$] Don't Ignore Big Pharma's New Breakthrough
finance.yahoo.com - September 5 at 5:56 PM
seekingalpha.com logoMonsanto: EU Launches In-Depth Probe Of Bayer Deal (Does It Matter?)
seekingalpha.com - September 4 at 3:54 PM
americanbankingnews.com logoBayer AG (BAYRY) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - September 2 at 2:44 AM
nasdaq.com logoPharma Stock Roundup: Novartis CAR-T Drug Gets FDA Nod, Lilly Gives Baricitinib Update - Nasdaq
www.nasdaq.com - September 1 at 8:34 PM
nasdaq.com logoJ&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III - Nasdaq
www.nasdaq.com - August 28 at 9:26 PM
finance.yahoo.com logoJ&J's (JNJ) Xarelto/Aspirin Regimen Positive in Phase III
finance.yahoo.com - August 28 at 9:26 PM

Social

Chart

Bayer AG (BAYRY) Chart for Thursday, October, 19, 2017

This page was last updated on 10/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.